Sinomab Bio-B (03681) announced interim results: 截至二零二六年六月三十日止六個月中期業績公告, net profit attributable to owners RMB-1.3bn Title: 截至二零二六年六月三十日止六個月中期業績公告 Net profit: RMB-1.3bn Profit attributable to owners: RMB-1.3bn
